Companies / Avalo Therapeutics, Inc. / Activity
Activity — Avalo Therapeutics, Inc.
7 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q3 2025 as of | Boxer Capital Management, LLC 13F manager | New | Common stock | $1.59M | +125K | 125,000 0.23% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | New | Common stock | $767.5K | +51K | 51,408 0.10% of shares | low |
| Q1 2026 as of | Prelude Capital Management, LLC 13F manager | New | Common stock | $524.0K | +35K | 35,096 0.07% of shares | low |
| Q4 2025 as of | Persistent Asset Partners Ltd 13F manager | New | Common stock | $274.0K | +15K | 15,087 0.03% of shares | low |
| Q1 2026 as of | Westfield Capital Management Company, L.P. 13F manager | New | Common stock | $233.5K | +16K | 15,639 0.03% of shares | low |
| Q3 2025 as of | Barclays PLC 13F manager | New | Common stock | $118.8K | +9K | 9,346 0.02% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common stock | $2.0K | +216 | 216 <0.01% of shares | low |